Literature DB >> 10786930

Insulin sensitivity in normotensive offspring of hypertensive parents.

H S Chen1, C M Hwu, C F Kwok, K C Shih, L C Hsiao, S H Lee, Y T Lin, S H Lin, L T Ho.   

Abstract

OBJECTIVES: To investigate the insulin sensitivity in normotensive offspring of hypertensive parents.
SUBJECTS: Fifteen young normotensive offspring of hypertensive parents were paired with 15 controls matched for age, sex and body mass index.
METHODS: The insulin sensitivity was investigated by 75 g oral glucose tolerance test (OGTT) and modified insulin suppression test. A high-fat mixed meal was administered to observe the changes of TG levels.
RESULTS: The plasma glucose and serum insulin responses to oral glucose challenge were comparable between both groups. High-fat mixed meal made no difference in the plasma glucose, serum triglyceride or insulin between the 2 groups. With the modified insulin suppression test, the steady-state plasma glucose levels (SSPG) were higher in the offspring of parents with essential hypertension (138+/-43 mg/dl) than in the control group (95+/-26 mg/dl). The diastolic blood pressure and heart rate of the offspring of hypertensive parents are also higher than the control group.
CONCLUSIONS: Insulin resistance exists in young normotensive offspring of hypertensive parents, and the impairment of insulin-mediated glucose uptake in these subjects develop before any alteration of fasting and postprandial triglyceride.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10786930     DOI: 10.1055/s-2007-978601

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  1 in total

1.  Endothelin Type A Receptor Genotype is a Determinant of Quantitative Traits of Metabolic Syndrome in Asian Hypertensive Families: A SAPPHIRe Study.

Authors:  Low-Tone Ho; Yung-Pei Hsu; Chin-Fu Hsiao; Chih-Tai Ting; Kuang-Chung Shih; Lee-Ming Chuang; Kamal Masaki; John Grove; Thomas Quertermous; Chi-Chung Juan; Ming-Wei Lin; Shu-Chiung Chiang; Yii-Der I Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2013-11-28       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.